Roche is handing over $595 million to bolster its Foundation Medicine business with a deal to snap up SAGA Diagnostics. | ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...

Another risk for investors to consider is that the company remains unprofitable. While the company seems to have reached an ...

At ESCMID Global 2026, Bruker announces important portfolio enhancements across microbial identification, outbreak analysis, and reflex next?generation sequencing (NGS) typing. These latest ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...

Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted ...

Transaction Details The transaction is subject to customary closing conditions and regulatory approvals. Under the terms of the agreement, Eurobio Scientific will acquire CareDx’s Lab Products ...

CareDx shares rose over 8% in extended trading on Wednesday after the precision medicine company said it will divest its Lab Products business to EuroBio Scientific for cash consi ...

Watchmaker Genomics, an innovator in high-performance tools for molecular diagnostic (MDx) assay developers, today announced the expansion of its MDx tools portfolio with the launch of Stellar RT-qPCR ...

Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis ...

COLLECT Solution provides significant advantages for minimally invasive self-collection of blood samples in community-based, ...